Oleg Nodelman Overview

  • Primary Position
  • Founder

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 10

  • Med. Deal Size

  • Med. Valuation

Oleg Nodelman General Information

Biography

Mr. Oleg Nodelmanserves as Non-Executive, Non-Independent Driver at Galapagos he is the Founder of EcoR1 Capital. He served as Portfolio Manager at EcoR1 Capital. He also served as Chief Executive Officer & Chairman at Panacea Acquisition Corp II & Board Member at Nuvation Bio. He serves as a Board Member at Epikast, Scorpion Therapeutics, ReCode Therapeutics, Aktis Oncology, and Paratus Sciences. He also served as Chief Executive Officer and Chairman at Panacea Acquisition. He is a Board Observer of Elevatebio. With 15 years of experience in investing and consulting, he has expertise in all aspects of investment management and deep roots in the biotech and scientific communities. Before founding EcoR1, he was a Portfolio Manager at BVF Partners, one of biotech's first dedicated hedge funds. During his 11 years with BVF, his responsibilities spanned the entire investment process, from opportunity generation and due diligence to portfolio management and trading. He began his career in strategic consulting and organizational management at Mercer Management Consulting (now Oliver Wyman), where he worked with senior management from companies in a variety of industries to develop and implement long-term strategies and build shareholder value. He is active in the biotech community, a member of the President's Council at the Gladstone Institute, and has served on the advisory committee of the Biotech Industry Organization. He serves as a Director at Prothena. He has a Bachelor of Science in Foreign Service with a concentration in Science and Technology from Georgetown University.

Contact Information

Primary Position
Founder, EcoR1 Capital
Education
Georgetown University, BS (Bachelor of Science)
Gender
Male
Email
ol
Phone
+1 (415)
Address
  • 357 Tehama Street
  • Floor 3
  • San Francisco, CA 94103
  • United States
+1 (415)

Oleg Nodelman Positions (1)

Firm name Firm type Title Location Industry Since
EcoR1 Capital Investor Founder San Francisco, CA Venture Capital

Oleg Nodelman Board Seats (11)

Company Industry Ownership Status Financing Status Location Since
Aktis Oncology Drug Discovery Privately Held (backing) Venture Capital-Backed Boston, MA
AnaptysBio Biotechnology Publicly Held Formerly VC-backed San Diego, CA
ElevateBio Biotechnology Privately Held (backing) Venture Capital-Backed Waltham, MA
Epikast Media and Information Services (B2B) Privately Held (backing) Venture Capital-Backed New York, NY
Galapagos Media and Information Services (B2B) Privately Held (backing) Venture Capital-Backed Tokyo, Japan

Oleg Nodelman Lead Partner on Deals (19)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Aktis Oncology 20-Sep-2024 Early Stage VC (Series B) Completed Drug Discovery Boston, MA
AnaptysBio 13-Aug-2024 Announced/In Progress Biotechnology San Diego, CA
Scorpion Therapeutics 16-Jul-2024 Completed Drug Discovery Boston, MA
ReCode Therapeutics 15-Sep-2023 Completed Drug Delivery Menlo Park, CA
Epikast 28-Feb-2023 Completed Media and Information Services (B2B) New York, NY
Paratus Sciences 27-Feb-2023 Completed Biotechnology New York, NY
Aktis Oncology 17-Aug-2022 Completed Drug Discovery Boston, MA
Actio Biosciences 28-Jul-2022 Completed Drug Discovery San Diego, CA
Nuvation Bio 10-Feb-2021 Reverse Merger Completed Drug Discovery New York, NY
Nuvation Bio 10-Feb-2021 PIPE Completed Drug Discovery New York, NY

Oleg Nodelman Network (271)

Board Members (118)

Name Company Representing Location From
Andrew Levin Aktis Oncology Self Boston, MA
Dean Mitchell ReCode Therapeutics ReCode Therapeutics Menlo Park, CA
Epikast Epikast New York, NY
Scorpion Therapeutics Mass General Brigham Innovation Boston, MA
Scorpion Therapeutics Self Boston, MA

Portfolio Executives (151)

Name Company Role Deal date Location
Patrick Baeuerle Ph.D Aktis Oncology Co-Founder & Advisor 20-Sep-2024 Boston, MA
Todd Foley Aktis Oncology Co-Founder & Chairman 20-Sep-2024 Boston, MA
Aktis Oncology Advisor, Scientific Advisory Board 20-Sep-2024 Boston, MA
Aktis Oncology Chief Executive Officer, President & Board Member 20-Sep-2024 Boston, MA
Aktis Oncology Chief Scientific Officer 20-Sep-2024 Boston, MA

Fund Team Members (2)

Name Investor Fund Fund Location
EcoR1 Capital San Francisco, CA
EcoR1 Capital San Francisco, CA

Oleg Nodelman Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
EcoR1 Venture Opportunity Fund EcoR1 Capital Venture - General Closed 2019
EcoR1 Capital Fund EcoR1 Capital Hedge Fund Open

Oleg Nodelman FAQs

  • Who is Oleg Nodelman?

    Mr. Oleg Nodelmanserves as Non-Executive, Non-Independent Driver at Galapagos he is the Founder of EcoR1 Capital.

  • How much does Oleg Nodelman typically invest?

    Oleg Nodelman's median deal size is .

  • What is Oleg Nodelman’s main position?

    Oleg Nodelman’s primary position is Founder.

  • What are the contact details for Oleg Nodelman?

    Oleg Nodelman’s email address is ol and his phone number is +1 (415) .

  • How many active board seats does Oleg Nodelman hold?

    Oleg Nodelman holds 11 board seats including Aktis Oncology, AnaptysBio, ElevateBio, Epikast, and Galapagos.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »